Table 2.
Univariate and multivariate analyses of ZIP family genes mRNA level and patient disease-free survival.
| Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P-value | HR | 95%CI | P-value | |
| SLC39A1 | 1.422 | 0.995–2.033 | 0.053 | |||
| SLC39A2 | 1.334 | 0.936–1.901 | 0.111 | |||
| SLC39A3 | 1.299 | 0.912–1.851 | 0.147 | |||
| SLC39A4 | 1.011 | 0.711–1.439 | 0.950 | |||
| SLC39A5 | 0.593 | 0.415–0.848 | 0.004 | 0.503 | 0.302–0.838 | 0.008 |
| SLC39A6 | 1.071 | 0.752–1.525 | 0.705 | |||
| SLC39A7 | 1.119 | 0.786–1.593 | 0.532 | |||
| SLC39A8 | 0.406 | 0.278–0.594 | 0.000 | 0.481 | 0.275–0.841 | 0.010 |
| SLC39A9 | 0.481 | 0.335–0.691 | 0.000 | 0.810 | 0.485–1.353 | 0.421 |
| SLC39A10 | 0.777 | 0.546–1.106 | 0.161 | |||
| SLC39A11 | 1.928 | 1.338–2.776 | 0.000 | 0.716 | 0.399–1.285 | 0.263 |
| SLC39A12 | 0.855 | 0.592–1.234 | 0.403 | |||
| SLC39A13 | 1.790 | 1.252–2.559 | 0.001 | 1.037 | 0.609–1.765 | 0.895 |
| SLC39A14 | 1.573 | 1.095–2.259 | 0.014 | 1.326 | 0.769–2.287 | 0.310 |
| Age | 1.343 | 0.945–1.911 | 0.100 | |||
| Gender | 1.389 | 0.939–2.056 | 0.100 | |||
| T stage | 2.517 | 2.043–3.102 | 0.000 | 0.805 | 0.434–1.494 | 0.493 |
| N stage | 4.690 | 2.293–9.592 | 0.000 | 1.901 | 0.857–4.218 | 0.114 |
| M stage | 8.595 | 5.918–12.483 | 0.000 | 1.340 | 0.519–3.460 | 0.545 |
| TNM stage | 2.678 | 2.247–3.191 | 0.000 | 2.391 | 1.215–4.706 | 0.012 |
| Grade | 3.026 | 2.345–3.904 | 0.000 | 1.319 | 0.907–1.918 | 0.148 |
HR, hazard ratio; CI, confidence interval; TNM, Tumor Node Metastasis. Mean differences were considered statistically significant when P <0.05.